Pharma IQ Members

Adverse Drug Reaction (ADR)

Adverse Drug Reaction (ADR) is an expression that describes harm associated with the use of given medications at a normal dose. Adverse events can range from mild to severe. Serious adverse drug reactions are those that can cause disability, are life-threatening, result in hospitalization or death, or are birth defects.

15 results
of 2
Pharma IQ

The Asia Pacific region is fast becoming the growth center of the worldwide pharmaceuticals market. By 2015, these markets are projected to account for almost a third of the total pharmaceutical sales worldwide. 

But with this increased...

Contributor: Pharma IQ
Tue, 05/08/2012
Andrea Charles

In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas for...

Contributor: Andrea Charles
Mon, 12/12/2011
Elie Magdalani

Pharmacology is the study of the effects of drugs. The other interesting branch known as the “clinical pharmacology” is interested in the effects of drugs in humans by which therapy is individualised according to the needs of each patient (based...

Contributor: Elie Magdalani
Mon, 07/04/2011
Pharma IQ

Many companies in the pharmaceutical industry have provisions in place to deal with pharmacovigilance and other so-called late phase issues, as they realise the important role they can play in boosting the market penetration of products and –...

Contributor: Pharma IQ
Wed, 05/18/2011
Elie Magdalani

Reported adverse events are an important tool for implementing a risk management program. An important contributing factor in the evolved AEs the condition of chronically ill patients taking a drug daily over the course of many years. Another...

Contributor: Elie Magdalani
Fri, 05/06/2011
Pharma IQ

By the end of 2011 China's pharmaceutical market will be the third largest in the world, contributing more than $40 billion (£25 billion) in annual sales by 2013, according to analysis from IMS Health. India's pharmaceutical market will be...

Contributor: Pharma IQ
Tue, 03/22/2011
Andrea Charles

Dr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to report adverse drug events (ADEs) and how...

Contributor: Andrea Charles
Tue, 03/22/2011
Elie Magdalani

“To undergo treatment you have to be very healthy, because apart from your sickness you have to withstand the medicine”. Molière (French Dramatist, 1622-1673)Although Molière was not a health care professional, but he understood very well that...

Contributor: Elie Magdalani
Thu, 12/16/2010
The Process of Drug Development: Time to Market

The term Drug Development covers a wide range of activities, from clinical trials to the creation of new compounds, all of which help drive a particular product to market. In its entirety, the process can take more than a decade, and cost...

Contributor: Pharma IQ
Tue, 11/09/2010
T. E. Gopala Krishna Murthy

Multiparticulates or multiple unit dosage forms are the discrete, small, repetitive units of drug particles which may or may not possess similar drug release pattern.  They can be tailored for pulsatile, controlled and or delayed, targeted drug...

Contributor: T. E. Gopala Krishna Murthy
Sun, 10/03/2010
15 results
of 2